Adalimumab Biosimilar Market Expected to Grow Steadily at a CAGR of 17.6% During 2022-2029
Global Adalimumab Biosimilar Market Overview:
In 2021, the global Adalimumab Biosimilar market was valued at US$ 0.79 Bn. and is projected to reach US$ 2.85 Bn. by 2029, growing at a compound annual growth rate (CAGR) of 17.6% during the forecast period.
Market Overview:
A dedicated research team conducted extensive primary and secondary research to...
0 Comments
0 Shares